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Hemangioblastomas are benign, highly vascular-ized tumors. They usually represent 2% to 15% of reported series of intramedullary spinal cord le-
sions.4,7,16,17,30,31 Progressive motor and sensitivity dysfunc-
tions are major symptoms of cervical and dorsal tumors, 
while bowel and bladder signs are typically associated 
with lower thoracic or lumbar tumors.4–6,11,14,17,31 Spinal 
hemangioblastomas can be superficial, while some lie 
deeply embedded within the spinal cord.5,6,11,17,18
MRI is the gold standard for the diagnosis and assess-
ment of intradural tumors. On MRI, hemangioblastomas 
appear as discrete nodular lesions, with homogeneous 
enhancement after Gd administration.1,3,6,10,19,27,32 Normal 
collateral findings are an edematous spinal cord with per-
ilesional cyst or associated syrinx.
Nevertheless, MRI may not always differentiate accu-
rately between different types of intramedullary tumors, 
in particular when they are associated with syringes or 
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Hemangioblastomas are benign, highly vascularized intramedullary lesions that may also extend into the intradural 
space. Surgery represents the standard therapy, with the goal of obtaining complete resection even at the risk of 
neurological morbidity. MRI is the gold standard for diagnosis and assessment of intramedullary tumors. Nevertheless, 
sometimes MRI may not accurately differentiate between different types of intramedullary tumors, in particular if they 
are associated with syringes or intra- and peritumoral cysts. This could subsequently affect surgical strategies. Intraop-
erative ultrasound (ioUS) has become in the last few years a very useful tool for use during neurosurgical procedures. 
Various ioUS modalities such as B-mode and Doppler have been applied during neurosurgical procedures. On the other 
hand, the use of contrast-enhanced ultrasound (CEUS) is not yet well defined and standardized in this field. We report 
a case of a young patient harboring a cervicothoracic intramedullary tumor, for which the preoperative neuroradiologi-
cal diagnosis was in favor of a diffuse astrocytoma with nodular components whereas ioUS demonstrated 3 distinct 
intramedullary nodules. CEUS showed highly vascularized lesions, compatible with hemangioblastomas. These findings, 
particularly those obtained with CEUS, allowed better definition of the lesions for diagnosis, enhanced understanding of 
the physiopathological aspects, and permitted the localization of all 3 nodules, thus limiting spinal cord manipulation and 
allowing complete resection of the lesions, with an uneventful postoperative neurological course.
To the best of our knowledge, this is the first report of the use of intraoperative CEUS in a case of intramedullary heman-
gioblastoma.
http://thejns.org/doi/abs/10.3171/2015.5.FOCUS15162
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intra- and peritumoral cysts. For this reason, the use of 
intraoperative imaging tools such as ultrasound (US) can 
be very helpful in formulating the surgical strategy.24
We report a case of a young patient harboring a cervi-
cothoracic intramedullary tumor. In this patient, preopera-
tive neuroradiological findings were in favor of a diffuse, 
infiltrative intramedullary lesion with multiple nodules. 
However, the use of intraoperative US (ioUS) and, in par-
ticular, of Doppler and contrast-enhanced US (CEUS) in-
dicated instead that there were 3 distinct highly vascular-
ized intramedullary cervical tumors. CEUS is a relatively 
new technique that has been applied in a number of ul-
trasonographic procedures related to the abdominal com-
partment and other organs.20,21 With the use of ultrasono-
graphic contrast agents (UCAs), in our case it was possible 
to obtain direct real-time characterization of neoplastic le-
sions, specifically in regard to their vascularization. Intra-
operative ultrasonographic findings that ultimately altered 
the surgical strategy in this case are reported in detail.
case report
History and Examination
A 14-year-old male patient was admitted to our institu-
tion in January 2015 with a long history of slowly pro-
gressive cervical and thoracic pain, usually arising during 
physical efforts. Neurological examination showed hypo-
sthenia of the right arm, more severe distally, with hypoes-
thesia of the same region. Symmetric hyperreflexia in all 
4 extremities was also noted.
MRI scans depicted diffuse alteration of the spinal 
cord at the C2–T2 level, which appeared enlarged, with 
an altered signal. Three nodular lesions were present at 
the T-4, T-1, and C-7 levels, with blurred margins, all sur-
rounded by cystic cavities along the spinal axis. After Gd 
injection all 3 nodules showed intense enhancement, as 
well as cyst capsules and altered spinal cord between the 
nodules. The neuroradiological diagnosis was that of a 
diffuse intramedullary tumor, compatible with an astro-
cytoma (Fig. 1).
Operation and Ultrasound Findings
To achieve a partial debulking and to obtain specimens 
for histopatological diagnosis, the patient underwent sur-
gery in the prone position, with the assistance of neuro-
physiological monitoring and US guidance. A posterior 
midline approach was performed. Laminae C-2 to T-4 and 
spinous processes were removed. To confirm the adequa-
cy of the bone removal before dural opening, ioUS was 
performed, as it has become our practice during surgery 
for spinal tumor at our institution. The surgical field was 
examined with transdural insonation through the poste-
rior laminotomy on both the axial and sagittal axes, using 
direct B-mode, Doppler, and CEUS. We used a last-gener-
ation US system (Esaote MyLab with Virtual Navigator) 
with a multifrequency (3–11 MHz) linear probe.
The standard B-mode imaging examination showed 
an enlarged edematous spinal cord with multiple cystic 
cavities (Fig. 2). Three ovular, hyperechoic lesions, with 
cranial cystic areas and an ill-defined border caudally, 
were present. It was not possible to differentiate edema-
Fig. 1. Preoperative MR images. Sagittal T1 cervical (A), thoracic (b), and axial T1 (c–e) post-Gd images. Panels A and B 
show widening of the spinal cord at the C2–T4 level, with 3 nodular lesions (arrows). Cyst capsules and the altered spinal cord in 
between the nodules show enhancement after Gd in panels C and E (arrowheads). In panel D nodular contrast enhancement is 
also visible (arrows).
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tous spinal cord from an infiltrative lesion. The Eco-Color 
Doppler mode showed multiple high- and low-flow vessels 
within the lesion and enlarged draining veins.
After having scanned the lesion with navigated US in 
B-mode and with color Doppler, we then decided to also 
perform intraoperative CEUS (iCEUS), as previously de-
scribed in other papers from our group.22,23 We followed 
the European Federation of Societies for Ultrasound in 
Medicine and Biology (EFSUMB) guidelines on CEUS,21 
in an off-label setting.
The US probe was positioned at the level of the larger 
lesion in a sagittal plane and the main lesion was iden-
tified; then we switched to the specific contrast-tuned 
imaging algorithm. Sulfur hexafluoride–filled lipidic mi-
crobubbles (SonoVue), a second-generation purely intra-
vascular UCA, was injected intravenously by the anesthe-
siologist, as a bolus of 2.4 mL (5 mg/mL), followed by 
a flush of 10 ml of saline solution. The UCA generally 
arrives in the observed field 30 seconds after injection, 
lasts in the bloodstream approximately 5 minutes, and is 
then excreted through the lungs and kidneys. The surgical 
field had been examined with iCEUS for approximately 3 
minutes, and the subsequent harmonic signals due to UCA 
vibration were elaborated.
All nodules were rapidly and highly enhanced com-
pared with the edematous spinal cord, along with feed-
ing arteries and draining veins (Fig. 3). CEUS showed that 
cyst capsules and altered spinal cord between the nodules 
did not present enhancement, discordantly from MRI find-
ings (Figs. 3 and 4). On the other hand, a nodular lesion 
at C-7, which protruded on the medullar surface, showed 
a rapid and homogeneous enhancement with a late wash-
out. A vascular peduncle was clearly identifiable. All these 
findings were in favor of hemangioblastoma. Caudally 
to this nodule, at the T3–T4 level, the medulla appeared 
edematous and hyperechoic; however, no superficial lesion 
was identifiable. Again, CEUS showed the presence of a 
deep-seated intramedullary nodule, with ultrasonographic 
characteristics similar to those of the first nodule (Fig. 5). 
With a delicate dissection along the spinal cord midline, 
we started to coagulate afferent vessels, and this lesion 
was also removed. Finally, a nodular lesion at the level of 
the right C-5 root was identified and removed.
All the tumors were completely removed with a micro-
neurosurgical technique. The D-wave did not show any 
change with respect to the basal level. Laminae removed 
were then replaced and secured to the surrounding ver-
Fig. 2. Intraoperative B-mode images prior to resection.  A–c: Axial scans of 3 nodular lesions (asterisks) surrounded by cystic 
cavities or syrinx.  d–F: Corresponding sagittal B-mode scans. It is not possible to clearly differentiate edematous spinal cord 
(triple arrows) from infiltrative lesion.
Fig. 3. Intraoperative CEUS visualization of 3 nodular lesions (A–c) 
compared with the corresponding preoperative post-Gd MRI scan visu-
alization (d).
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tebral bone with titanium plates and self-tapping screws 
(Fig. 6).
The histological diagnosis confirmed the intraoperative 
ultrasonographic findings, and it was in favor of heman-
gioblastomas. The patient had an uneventful postopera-
tive course. Two months after surgery he fully recovered 
his motor symptoms, and only a mild hypoesthesia of the 
right hand was still present.
discussion
Hemangioblastomas usually have a very discrete tu-
mor–spinal cord interface and do not infiltrate the spinal 
cord substance. The resection of the lesion also usually 
determines syrinx improvement; no syrinx cavity drain-
age is necessary.5,14,17,29 Recurrence is in most cases due 
to incomplete resection; therefore, accurate surgical plan-
ning is mandatory. MRI represents the gold standard for 
the diagnosis of intradural tumors; however, as shown in 
this case, MRI findings can sometimes be misinterpreted. 
In fact, the spinal cord at the C2–T2 level appeared en-
larged, with altered signal. Cyst capsules showed intense 
enhancement after Gd injection on T1-weighted images, 
appearing as nodular lesions, and were therefore consid-
ered as cystic degeneration of the solid nodular compo-
nents, not as tumor-associated syringomielic cavities.
Only the ultrasonographic examination, in particu-
lar after UCA administration, showed actual findings: 
B-mode US delineated 3 distinct hyperechoic nodules 
within an otherwise hyperechoic spinal cord. iCEUS 
Fig. 4. A: Both the lesion (asterisk) and the spinal cord (arrow) appear 
hyperechoic at B-mode examination.  b: The contrast enhancement 
of the lesion (asterisks) is clearly visible, with a dotted homogeneous 
pattern, while the spinal cord (arrow) is not enhancing. These findings 
are different from those of the preoperative MRI scans (c), in which the 
spinal cord (arrow) is also enhanced after Gd administration, giving the 
impression of an infiltrative diffuse lesion.
Fig. 5. Time frame of UCA diffusion in the T3–T4 hemangioblastoma. The contrast medium allows rapid visualization of the lesion, 
reaching a peak of enhancement after 10 seconds from intravenous injection. MI = mechanical index; s = seconds.
Fig. 6. left: Postoperative MRI showing removal of tumors. Initial 
reduction of the cervical syrinx is visible.  right: CT scans depicting 
reposition of laminae.
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clearly highlighted the 3 nodules along with their feeding 
and draining vessels while not enhancing the spinal cord, 
particularly in the areas where the MRI was misleading, 
showing Gd enhancement. This difference might be ex-
plained by the different nature of the 2 contrast agents: 
UCAs are purely intravascular while MRI paramagnetic 
contrast agents are vascular and interstitial. The post-Gd 
enhancement at MRI of the perilesional cysts and edema-
tous spinal cord could be explained by the increased in-
tramedullary venous pressure due to the high-flow lesions 
that caused a local venous congestion with possible ex-
travasation and diffusion in the interstitial compartment, 
while UCA, being the size of a red blood cell, remained 
within the vascular spaces.
In spinal tumor US-guided surgery, the B-mode exami-
nation is usually sufficient to depict the lesions prior to 
dural opening.2,8,12,13,26,28,33 However, in certain cases the 
use of other US techniques as adjuncts could be helpful in 
better characterizing the nature of the lesions, in particular 
if they present as intramedullary.
Intraoperative US with color Doppler can be used to 
visualize an encased tumor or displaced vessels and the 
origin of the vascular supply to the main tumor. It facili-
tates the identification of important neurovascular struc-
tures during tumor removal but nonetheless presents cer-
tain limitations: low-flow veins are not always visible and 
small vessels may be overestimated due to blooming arti-
facts.9 Furthermore, it may be difficult to follow displaced 
vessels with a proper insonation angle because they do not 
have a linear course and also because of the limit imposed 
by the margins of bone removal, which reduces the accu-
racy of the Doppler signal.9
Over the years, a number of studies regarding UCA ap-
plication in liver and many other organs have been per-
formed.15,25 On the other hand, the intraoperative applica-
tion of CEUS in neurosurgery is still limited. As already 
established for brain tumor surgery, iCEUS is a valuable 
tool to better highlight cerebral lesions and obtain addi-
tional information regarding their vascular and perfusion 
patterns.
Relying on our experience with iCEUS in brain tumor 
surgery,22,23 we decided to use this method in this case. 
CEUS allowed us to further highlight the lesion and dif-
ferentiate it from an infiltrative spinal cord tumor like as-
trocytoma. In particular, the polar cystic areas and spinal 
cord did not show contrast enhancement, differently from 
MRI findings. On the other hand, the nodular Doppler and 
CEUS characteristics were in favor of a noninfiltrative le-
sion, like hemangioblastoma.
One possible limitation of the CEUS technique is that 
the analysis could be performed only by analyzing one 
portion of the lesion at a time. It is consequently mandato-
ry to accurately scan the lesion in B-mode and color Dop-
pler imaging before performing iCEUS. This is necessary 
to evaluate the more significant portion of the lesion and 
to obtain as much information as possible in regard to the 
timing. As demonstrated in our case, a correlation between 
iCEUS and preoperative MRI (T1-weighted Gd) presents 
some major obstacles when comparing the degree of en-
hancement after contrast between the techniques. In fact, 
microbubbles are purely intravascular, whereas MRI con-
trast agent is mainly interstitial. Furthermore, CEUS is a 
dynamic perfusion imaging, and MRI is static.
All ioUS findings were very useful in approaching this 
lesion, and iCEUS offered further insight, highlighting the 
lesion and describing its perfusion pattern. This led to a 
change of surgical strategy and helped us to achieve total 
resection of the tumors.
In our experience, iCEUS has proven to be a simple and 
relatively inexpensive technique representing a real-time 
dynamic procedure that can be performed during spinal 
tumor surgery. The ability of iCEUS to highlight vascular 
structures made it easier for the surgeon to identify the 
vascular peduncles, giving further insight into the surgical 
strategy and facilitating vascular deafferentation of the le-
sion and then its surgical removal.
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